Kursprognose für Nuvectis Pharma Inc (NVCT)NVCTNuvectis Pharma Inc

Alphio's NVCT stock price prediction model matches the current Nuvectis Pharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $20.55 (-0.19%). The 1-week path is $21.90 (+6.36%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Nuvectis Pharma Inc is currently trading at $18.60, which is below the lowest analyst price target of $22. However, the stock has shown a significant decline of 11.93% over the past 5 days and has a low RSI of 37.199, indicating potential oversold conditions. The company has a concerning forward P/E ratio of 0 and a negative net income of $6.05 million in Q1 2026, which raises concerns about its financial health. While the recent approval of Ciprocopan in China is a positive catalyst, the stock's recent performance and high volatility suggest caution. The main risk is the ongoing negative earnings trend, with a net loss of $7 million reported in the last quarter, which could impact future financing capabilities.

Nuvectis Pharma Inc (NVCT) last closed at $20.59, gaining +8.71%. These facts feed the 1-day and 1-week NVCT price prediction above.